HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus.
Kathryn A LurainRamya RamaswamiLaurie T KrugDenise WhitbyJoseph M ZiegelbauerHao-Wei WangRobert YarchoanPublished in: Clinical microbiology reviews (2024)
SUMMARYWithin weeks of the first report of acquired immunodeficiency syndrome (AIDS) in 1981, it was observed that these patients often had Kaposi sarcoma (KS), a hitherto rarely seen skin tumor in the USA. It soon became apparent that AIDS was also associated with an increased incidence of high-grade lymphomas caused by Epstein-Barr virus (EBV). The association of AIDS with KS remained a mystery for more than a decade until Kaposi sarcoma-associated herpesvirus (KSHV) was discovered and found to be the cause of KS. KSHV was subsequently found to cause several other diseases associated with AIDS and human immunodeficiency virus (HIV) infection. People living with HIV/AIDS continue to have an increased incidence of certain cancers, and many of these cancers are caused by EBV and/or KSHV. In this review, we discuss the epidemiology, virology, pathogenesis, clinical manifestations, and treatment of cancers caused by EBV and KSHV in persons living with HIV.
Keyphrases
- epstein barr virus
- antiretroviral therapy
- human immunodeficiency virus
- hiv aids
- hiv infected
- hiv positive
- diffuse large b cell lymphoma
- high grade
- risk factors
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- ejection fraction
- hepatitis c virus
- prognostic factors
- low grade
- patient reported outcomes
- south africa
- wound healing
- case report